Trump's FDA nominee under review after outbreak
Heidi Overton, a Trump administration appointee and White House aide, faces a challenging confirmation process to lead the FDA amid a summer of extensive foodborne illness outbreaks, including a surge in cyclospora infections linked to contaminated lettuce. The outbreaks have raised concerns about the agency’s capacity, with critics citing staffing cuts and delayed responses that have eroded public trust. Supporters praise Overton as a capable leader, but skepticism remains over her potential to prioritize political interests over science amid ongoing leadership turmoil and policy controversies.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)